You are here
CERID Bibliography
Export 19 results:
Author Title [ Type] Year Filters: Keyword is Animals and Author is Buckner, F S [Clear All Filters]
Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine. J Med Chem. 2000 ;43(22):4135-50.
. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. J Med Chem. 2001 ;44(13):2080-93.
Centrally administered inhibitors of the generation and action of angiotensin II do not attenuate the increase in ACTH secretion produced by ether stress in rats. Neuroendocrinology. 1986 ;42(2):97-101.
. Cloning and functional characterization of a Trypanosoma brucei lanosterol 14alpha-demethylase gene. Mol Biochem Parasitol. 2001 ;117(1):115-7.
. Cloning and heterologous expression of the Trypanosoma brucei lanosterol synthase gene. Mol Biochem Parasitol. 2000 ;110(2):399-403.
. Cloning, heterologous expression, and distinct substrate specificity of protein farnesyltransferase from Trypanosoma brucei. J Biol Chem. 2000 ;275(29):21870-6.
. Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase. Infect Immun. 1999 ;67(1):403-9.
. The effects of protein farnesyltransferase inhibitors on trypanosomatids: inhibition of protein farnesylation and cell growth. Mol Biochem Parasitol. 1998 ;94(1):87-97.
. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob Agents Chemother. 1996 ;40(11):2592-7.
. Expression of mammalian cytokines by Trypanosoma cruzi indicates unique signal sequence requirements and processing. Mol Biochem Parasitol. 1995 ;75(1):25-31.
. Induction of resistance to azole drugs in Trypanosoma cruzi. Antimicrob Agents Chemother. 1998 ;42(12):3245-50.
. Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors. Antimicrob Agents Chemother. 2001 ;45(4):1210-5.
. Protein farnesyltransferase from Trypanosoma brucei. A heterodimer of 61- and 65-kda subunits as a new target for antiparasite therapeutics. J Biol Chem. 1998 ;273(41):26497-505.
. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A. 1999 ;96(8):4273-8.
. TcRho1, a farnesylated Rho family homologue from Trypanosoma cruzi: cloning, trans-splicing, and prenylation studies. J Biol Chem. 2001 ;276(32):29711-8.
Trypanosoma cruzi: expression of interleukin-2 utilizing both supercoiled plasmids and linear DNAs. Exp Parasitol. 1996 ;83(1):159-63.
. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes. Eur J Immunol. 1997 ;27(10):2541-8.
. Trypanosoma cruzi: use of herpes simplex virus-thymidine kinase as a negative selectable marker. Exp Parasitol. 1997 ;86(3):171-80.
. Trypanosome and animal lanosterol synthases use different catalytic motifs. Org Lett. 2001 ;3(12):1957-60.
.